NCT03479346View on ClinicalTrials.gov

Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 28, 2018

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2020

Conditions
ObesityMetabolic Syndrome
Interventions
DRUG

GGT

Usage: 3g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

DRUG

Placebo

Usage: 3g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Trial Locations (1)

Unknown

Gachon University Gil Oriental Medical Hospital, Incheon

All Listed Sponsors
collaborator

DongGuk University

OTHER

collaborator

Wonkwang University Guangju Medical Center

UNKNOWN

collaborator

Dongsin University Oriental Hospital

UNKNOWN

collaborator

Kyunghee University Medical Center

OTHER

lead

Gachon University Gil Oriental Medical Hospital

OTHER

NCT03479346 - Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial | Biotech Hunter | Biotech Hunter